Visfatin Amplifies Cardiac Inflammation and Aggravates Cardiac Injury via the NF-κB p65 Signaling Pathway in LPS-Treated Mice

Figure 3

Effects of visfatin on cardiac inflammation in LPS-treated mice. (a) Cardiac CD3+ cells and CD68+ cells in the four groups were examined. (b) The expression of MCP-1, TNF-α, IFN-γ, IL-1β, IL-6, IL-12, IL-17, and IL-18 in the heart and serum was detected. (c) The activation of the NF-κB p65 pathway was measured. in each group. vs. the saline + PBS group. ^# vs. the LPS + PBS group.

(a)

(b)

(c)